Opioid-Free Anesthesia (OFA) as a Safe Anesthetic Choice for Epilepsy Patient
DOI:
https://doi.org/10.37275/bsm.v7i12.901Keywords:
Epilepsy, Nasal cavity tumor, Opioid-free anesthesia, RhinotomyAbstract
Background: The opioid-free anesthesia (OFA) approach, although not widely employed in anesthesia, offers distinct benefits for some populations, such as epilepsy patients, due to the propensity of opioids to trigger seizures. Hence, the objective of this study was to conduct an opioid-free anesthesia (OFA) procedure on the left lateral rhinotomy in a patient with concurrent epilepsy.
Case presentation: Our patient is a 59-year-old woman suffering from epilepsy with a left nasal cavity tumor, scheduled for a left midfacial degloving rhinotomy. Given the patient's epilepsy comorbid, we have opted for an opioid-free anesthesia (OFA) procedure. OFA procedures are not yet widely employed in anesthesia; however, they offer advantages for specific patient populations, including epilepsy patients, as opioids have the potential to induce seizures.
Conclusion: The various OFA protocols being conducted worldwide require refinement, and the potential interactions of each component should be explored further.
Authors
- Albertus Medianto Walujo1*
- Dewa Ayu Mas Shintya Dewi2
- FX. Adinda Putra Pradhana3
- 1Resident, Department of Anesthesiology and Intensive Therapy, Universitas Udayana/Prof. Dr. I.G.N.G Ngoerah General Hospital, Denpasar, Indonesia
- 2Department of Anesthesiology and Intensive Therapy, Universitas Udayana/Prof. Dr. I.G.N.G Ngoerah General Hospital, Denpasar, Indonesia
- 3Department of Anesthesiology and Intensive Therapy, Universitas Udayana, Udayana Hospital, Jimbaran, Indonesia
Corresponding author Albertus Medianto Walujo — medbius2022@gmail.com
Article history
- Submitted
- Accepted
- Published
Downloads
Published
Issue
Section
License
As our aim is to disseminate original research article, hence the publishing right is a necessary one. The publishing right is needed in order to reach the agreement between the author and publisher. As the journal is fully open access, the authors will sign an exclusive license agreement.
The authors have the right to:
- Share their article in the same ways permitted to third parties under the relevant user license.
- Retain copyright, patent, trademark and other intellectual property rights including research data.
- Proper attribution and credit for the published work.
For the open access article, the publisher is granted to the following right.
- The non-exclusive right to publish the article and grant right to others.
- For the published article, the publisher applied for the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
